Published online March 1, 2006
PEDIATRICS Vol. 117 No. 3 March 2006, pp. 626-632 (doi:10.1542/peds.2005-1362)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow P3Rs: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (50)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garin, E. H.
Right arrow Articles by Young, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garin, E. H.
Right arrow Articles by Young, L.
Related Collections
Right arrow Genitourinary Tract

Clinical Significance of Primary Vesicoureteral Reflux and Urinary Antibiotic Prophylaxis After Acute Pyelonephritis: A Multicenter, Randomized, Controlled Study

Eduardo H. Garin, MDa, Fernando Olavarria, MDb, Victor Garcia Nieto, MDc, Blanca Valenciano, MDd, Alfonso Campos, MDa and Linda Young, PhDe

a Department of Pediatrics, University of South Florida, Tampa, Florida
b Universidad Austral, Valdivia, Chile
c Hospital Nuestra Senora de la Candelaria, Tenerife, Spain
d Hospital Las Palmas, Gran Canaria, Spain
e Department of Pediatrics, University of Florida, Gainesville, Florida

OBJECTIVES. To evaluate the role of primary vesicoureteral reflux (VUR) in increasing the frequency and severity of urinary tract infections (UTIs) and renal parenchymal damage among patients with acute pyelonephritis and to determine whether urinary antibiotic prophylaxis reduces the frequency and/or severity of UTIs and/or prevents renal parenchymal damage among patients with mild/moderate VUR.

METHODS. Patients 3 months to 18 years of age with acute pyelonephritis, with or without VUR, were assigned randomly to receive urinary antibiotic prophylaxis or not. Patients were monitored every 3 months for 1 year. Dimercaptosuccinic acid renal scans were repeated at 6 months or if there was a recurrence of febrile UTI. Urinalysis and urine culture were performed at each clinic visit. Renal ultrasound scans and voiding cystourethrograms were repeated at the end of 1 year of follow-up monitoring.

RESULTS. Of the 236 patients enrolled in the study, 218 completed the 1-year follow-up monitoring. Groups were similar with respect to age, gender, and reflux grade distribution for those with VUR. No statistically significant differences were found among the groups with respect to rate of recurrent UTI, type of recurrence, rate of subsequent pyelonephritis, and development of renal parenchymal scars.

CONCLUSIONS. After 1 year of follow-up monitoring, mild/moderate VUR does not increase the incidence of UTI, pyelonephritis, or renal scarring after acute pyelonephritis. Moreover, a role for urinary antibiotic prophylaxis in preventing the recurrence of infection and the development of renal scars is not supported by this study.


Key Words: vesicoureteral reflux • urinary antibiotic prophylaxis • acute pyelonephritis

Abbreviations: VUR—vesicoureteral reflux • UTI—urinary tract infection • DMSA—dimercaptosuccinic acid • VCUG—voiding cystourethrogram


Accepted Jul 25, 2005.




This article has been cited by other articles:


Home page
PediatricsHome page
M. Pennesi, L. Travan, L. Peratoner, A. Bordugo, A. Cattaneo, L. Ronfani, S. Minisini, A. Ventura, and for the North East Italy Prophylaxis in VUR study
Is Antibiotic Prophylaxis in Children With Vesicoureteral Reflux Effective in Preventing Pyelonephritis and Renal Scars? A Randomized, Controlled Trial
Pediatrics, June 1, 2008; 121(6): e1489 - e1494.
[Abstract] [Full Text] [PDF]


Home page
AAP Grand RoundsHome page
L. S. Palmer
Antibiotic Prophylaxis for Vesicoureteral Reflux Revisited
AAP Grand Rounds, May 1, 2008; 19(5): 49 - 50.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Williams, J. T. Fletcher, S. I. Alexander, and J. C. Craig
Vesicoureteral Reflux
J. Am. Soc. Nephrol., May 1, 2008; 19(5): 847 - 862.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
F. Bouissou, C. Munzer, S. Decramer, B. Roussel, R. Novo, D. Morin, M. P. Lavocat, C. Guyot, S. Taque, M. Fischbach, et al.
Prospective, Randomized Trial Comparing Short and Long Intravenous Antibiotic Treatment of Acute Pyelonephritis in Children: Dimercaptosuccinic Acid Scintigraphic Evaluation at 9 Months
Pediatrics, March 1, 2008; 121(3): e553 - e560.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. H. Conway, A. Cnaan, T. Zaoutis, B. V. Henry, R. W. Grundmeier, and R. Keren
Recurrent Urinary Tract Infections in Children: Risk Factors and Association With Prophylactic Antimicrobials
JAMA, July 11, 2007; 298(2): 179 - 186.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
E. H. Garin and L. Young
Much Pain, Little Gain From Voiding Cystourethrogram After Urinary Tract Infection
Pediatrics, July 1, 2007; 120(1): 249 - 250.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
S. D Marks
How have the past 5 years of research changed clinical practice in paediatric nephrology?
Arch. Dis. Child., April 1, 2007; 92(4): 357 - 361.
[Abstract] [Full Text] [PDF]


Home page
Pediatr. Rev.Home page
D. G. Bundy and J. R. Serwint
Vesicoureteral Reflux
Pediatr. Rev., February 1, 2007; 28(2): e6 - e8.
[Full Text] [PDF]


Home page
PediatricsHome page
N. M. Oreskovic and E. U. Sembrano
Repeat Urine Cultures in Children Who Are Admitted With Urinary Tract Infections
Pediatrics, February 1, 2007; 119(2): e325 - e329.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
T. B. Newman
Much Pain, Little Gain From Voiding Cystourethrograms After Urinary Tract Infection
Pediatrics, November 1, 2006; 118(5): 2251 - 2251.
[Full Text] [PDF]


Home page
PediatricsHome page
E. R. Wald
Much Pain, Little Gain From Voiding Cystourethrograms After Urinary Tract Infection: In Reply
Pediatrics, November 1, 2006; 118(5): 2251a - 2252.
[Full Text] [PDF]


Home page
Evid. Based Med.Home page
R. Lehman
Evidently...
Evid. Based Med., October 1, 2006; 11(5): 136 - 136.
[Full Text] [PDF]


Home page
Evid. Based Med.Home page
Other articles noted
Evid. Based Med., October 1, 2006; 11(5): 159 - 160.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
JOURNAL WATCH PEDIATRICS & ADOLESCENT MEDICINE
Arch. Dis. Child., August 1, 2006; 91(8): 712 - 713.
[Full Text] [PDF]


Home page
AAP NewsHome page
H. G. Rushton
`Top down' approach to evaluating children with UTIs shows promise
AAP News, June 1, 2006; 27(6): 14 - 15.
[Full Text]


Home page
JWatch PediatricsHome page
Antibiotic Prophylaxis for Vesicoureteral Reflux May Not Be Necessary
Journal Watch Pediatrics and Adolescent Medicine, April 21, 2006; 2006(421): 3 - 3.
[Full Text]


Home page
JWatch GeneralHome page
UTIs, Vesicoureteral Reflux, and Antibiotic Prophylaxis
Journal Watch (General), March 28, 2006; 2006(328): 5 - 5.
[Full Text]


Home page
PediatricsHome page
E. R. Wald
Vesicoureteral Reflux: The Role of Antibiotic Prophylaxis
Pediatrics, March 1, 2006; 117(3): 919 - 922.
[Full Text] [PDF]

P3Rs:

Read all P3Rs

Antibiotic prophylaxis probably still has a role in preventing UTIs following acute pyelonephritis
Deepak Ganapathy, et al.
Pediatrics Online, 3 May 2006 [Full text]